Piroximone
- Level
- Commodity
- Parent
- 51392200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51392212This classification denotes a phosphodiesterase inhibitor with the molecular formula C11H11N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2VSD0380YB, chemically known as 2h-imidazol-2-one, 4-ethyl-1,3-dihydro-5-(4-pyridinylcarbonyl)- but generally known as piroximone, which bears US NIH Compound Identifier 55263. European Medicines Agency schedules Piroximone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09938MIG. The term PIROXIMONE is an International Non-Proprietary Name. PIROXIMONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule piroximone under HS 29333999 and SITC 51574. As of Q4 2014, PIROXIMONE remains the US FDA Preferred Term for this commodity. Piroximone bears US NLM identifiers UMLS ID C0071150 and NCI Concept Code C90921. SMILES: CCC1=C(NC(=O)N1)C(=O)C2=CC=NC=C2.
Same parent
Under 51392200 · 30Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.